Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

LAT 8881 -Lateral Pharma

Next Previous
Drug Profile

LAT 8881 -Lateral Pharma

Alternative Names: Advanced Obesity Drug 9604; AOD9604; LAT-8881; Tyr-hGH171191

Latest Information Update: 28 Jun 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Monash University
  • Developer Lateral Pharma Pty Ltd; Metabolic Pharmaceuticals
  • Class Analgesics; Antimigraines; Peptide fragments; Peptide hormones
  • Mechanism of Action Neuron inhibitors; Somatotropin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Migraine; Neuropathic pain
  • No development reported Osteoporosis; Pain
  • Discontinued Obesity

Most Recent Events

  • 28 Jun 2025 No recent reports of development identified for phase-I development in Pain in Australia (IV, Infusion)
  • 28 May 2025 No recent reports of development identified for preclinical development in Pain in Australia (PO)
  • 05 Aug 2024 Pharmacokinetics and pharmacodynamics data from a phase I trial in Pain presented at the 20th World Congress on Pain (WCP-2024)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top